{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:46:57Z","timestamp":1786985217547,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.biopha.2016.09.015","type":"journal-article","created":{"date-parts":[[2016,9,17]],"date-time":"2016-09-17T07:45:17Z","timestamp":1474098317000},"page":"139-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Down-regulated PLAC8 promotes hepatocellular carcinoma cell proliferation by enhancing PI3K\/Akt\/GSK3\u03b2\/Wnt\/\u03b2-catenin signaling"],"prefix":"10.1016","volume":"84","author":[{"given":"Lei","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Jun","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biopha.2016.09.015_bib0005","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA : Cancer J. Clin."},{"issue":"2 Suppl. 1","key":"10.1016\/j.biopha.2016.09.015_bib0010","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1002\/lt.20052","article-title":"Surgical treatment of hepatocellular carcinoma: similar long-term results despite geographic variations","volume":"10","author":"Pawlik","year":"2004","journal-title":"Liver Transplant."},{"issue":"8","key":"10.1016\/j.biopha.2016.09.015_bib0015","first-page":"436","article-title":"Advances in targeted therapies for hepatocellular carcinoma in the genomic era, nature reviews","volume":"12","author":"Llovet","year":"2015","journal-title":"Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2016.09.015_bib0020","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2174\/156800913804486584","article-title":"Apoptosis suppression by candidate oncogene PLAC8 is reversed in other cell types","volume":"13","author":"Mourtada-Maarabouni","year":"2013","journal-title":"Curr. Cancer Drug Targets"},{"issue":"5","key":"10.1016\/j.biopha.2016.09.015_bib0025","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.cmet.2011.08.008","article-title":"Plac8 is an inducer of C\/EBPbeta required for brown fat differentiation, thermoregulation, and control of body weight","volume":"14","author":"Jimenez-Preitner","year":"2011","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.biopha.2016.09.015_bib0030","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3892\/ijo.2013.1954","article-title":"Induction of retinol-binding protein 4 and placenta-specific 8 expression in human prostate cancer cells remaining in bone following osteolytic tumor growth inhibition by osteoprotegerin","volume":"43","author":"Uehara","year":"2013","journal-title":"Int. J. Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2016.09.015_bib0035","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1172\/JCI71103","article-title":"Excess PLAC8 promotes an unconventional ERK2-dependent EMT in colon cancer","volume":"124","author":"Li","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"51","key":"10.1016\/j.biopha.2016.09.015_bib0040","doi-asserted-by":"crossref","first-page":"7524","DOI":"10.1038\/sj.onc.1208897","article-title":"Onzin, a c-Myc-repressed target, promotes survival and transformation by modulating the Akt-Mdm2-p53 pathway","volume":"24","author":"Rogulski","year":"2005","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.biopha.2016.09.015_bib0045","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.celrep.2014.03.061","article-title":"Plac8 links oncogenic mutations to regulation of autophagy and is critical to pancreatic cancer progression","volume":"7","author":"Kinsey","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2016.09.015_bib0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1471-2105-6-97","article-title":"Many accurate small-discriminatory feature subsets exist in microarray transcript data: biomarker discovery","volume":"6","author":"Grate","year":"2005","journal-title":"BMC Bioinformatics"},{"issue":"8","key":"10.1016\/j.biopha.2016.09.015_bib0055","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.4049\/jimmunol.178.8.5132","article-title":"Impaired host defense in mice lacking ONZIN","volume":"178","author":"Ledford","year":"2007","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"issue":"30","key":"10.1016\/j.biopha.2016.09.015_bib0060","doi-asserted-by":"crossref","first-page":"30130","DOI":"10.18632\/oncotarget.4967","article-title":"Vaccinia-related kinase 1 promotes hepatocellular carcinoma by controlling the levels of cell cycle regulators associated with G1\/S transition","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.biopha.2016.09.015_bib0065","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","article-title":"PI3K\/Akt signalling pathway and cancer","volume":"30","author":"Vara","year":"2004","journal-title":"Cancer Treat. Rev."},{"issue":"6","key":"10.1016\/j.biopha.2016.09.015_bib0070","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/\u03b2-catenin signaling and disease","volume":"149","author":"Clevers","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2016.09.015_bib0075","doi-asserted-by":"crossref","first-page":"26781","DOI":"10.1038\/srep26781","article-title":"miR-9 and miR-124 synergistically affect regulation of dendritic branching via the AKT\/GSK3beta pathway by targeting Rap2a","volume":"6","author":"Xue","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2016.09.015_bib0080","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.critrevonc.2016.06.007","article-title":"Hepatocellular carcinoma: exploring the impact of ethnicity on molecular biology","volume":"105","author":"Lamarca","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"2","key":"10.1016\/j.biopha.2016.09.015_bib0085","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.3892\/mmr.2015.3602","article-title":"Acylglycerol kinase promotes the proliferation and cell cycle progression of oral squamous cell carcinoma","volume":"12","author":"Liu","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2016.09.015_bib0090","first-page":"89","article-title":"Possible relevance of tumor-related genes mutation to malignant transformation of endometriosis","volume":"37","author":"Ma","year":"2016","journal-title":"Eur. J. Gynaecol. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2016.09.015_bib0095","doi-asserted-by":"crossref","first-page":"e981447","DOI":"10.4161\/23723556.2014.981447","article-title":"To die, or not to die: E2F1 never decides by itself during serum starvation","volume":"2","author":"Sakamuro","year":"2015","journal-title":"Mol. Cell. Oncol."},{"key":"10.1016\/j.biopha.2016.09.015_bib0100","doi-asserted-by":"crossref","DOI":"10.1177\/1535370216647184","article-title":"Analysis of hepatic microRNA alterations in response to hepatitis B virus infection and pegylated interferon alpha-2a treatment","author":"Jinato","year":"2016","journal-title":"Exp. Biol. Med. (Maywood, N. J.)"},{"issue":"21","key":"10.1016\/j.biopha.2016.09.015_bib0105","doi-asserted-by":"crossref","first-page":"30760","DOI":"10.18632\/oncotarget.8953","article-title":"Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling","volume":"7","author":"Kristensen","year":"2016","journal-title":"Oncotarget"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216310678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216310678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:34:59Z","timestamp":1773873299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332216310678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":21,"alternative-id":["S0753332216310678"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2016.09.015","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Down-regulated PLAC8 promotes hepatocellular carcinoma cell proliferation by enhancing PI3K\/Akt\/GSK3\u03b2\/Wnt\/\u03b2-catenin signaling","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2016.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}